Middle cranial fossa meningioma is a usually slow-growing tumor that starts in the lining around the brain near the temples. It often affects adults, especially older adults, and some people have no symptoms at first. Early symptoms of middle cranial fossa meningioma can include headaches, seizures, hearing changes, vision problems, or weakness and numbness if nearby nerves or brain tissue are pressed. Not everyone will have the same experience, but this condition often lasts for years and treatment may include monitoring, surgery, and sometimes radiation therapy. Many living with middle cranial fossa meningioma do well, though the outlook depends on the tumor size, exact location, growth rate, and whether it can be fully treated.
How many people live with Middle cranial fossa meningioma?
Global and U.S. estimates for middle cranial fossa meningioma, a meningioma in a specific part of the skull base, are not consistently reported by a single authoritative source. For context, more than 170,000 people in the United States are estimated to be living with meningioma overall (National Brain Tumor Society, 2024), but a reliable worldwide or U.S. count for the middle cranial fossa group is not available.
Overview
Middle cranial fossa meningiomaSymptoms
Middle cranial fossa meningioma can cause headaches, seizures, hearing changes, facial numbness, or weakness. Early symptoms of middle cranial fossa meningioma often depend on which nearby nerves or brain areas are being pressed.
Outlook and prognosis
Many people with middle cranial fossa meningioma do well, especially when the tumor grows slowly and can be fully removed or watched safely. Outlook depends on size, growth, nearby nerve or brain pressure, and whether symptoms such as vision changes or seizures improve with treatment.
Causes and risk factors
Middle cranial fossa meningioma risk rises with older age, prior head radiation, and female sex hormones. Some people also have an inherited condition called NF2, while obesity may slightly raise risk.
Genetic influences
Genetics usually matter less for middle cranial fossa meningioma than for many inherited conditions, since most cases are not clearly passed down in families. Still, gene changes in the tumor can affect growth, and rare inherited syndromes can raise risk.
Diagnosis
Middle cranial fossa meningioma is usually diagnosed with a neurologic exam and brain imaging, especially MRI and sometimes CT. A biopsy after surgery may confirm the diagnosis of Middle cranial fossa meningioma and rule out similar growths.
Treatment and drugs
Treatment for middle cranial fossa meningioma depends on its size, growth, and symptoms. Many people are monitored with repeat MRI scans, while bothersome tumors may be treated with surgery or focused radiation. Medicines can help with seizures, headaches, or swelling.
Symptoms
Symptoms of middle cranial fossa meningioma often build slowly and can be easy to miss at first, especially when the tumor is small. The changes are often subtle at first, blending into daily life until they become more noticeable. Depending on the exact spot, many people with middle cranial fossa meningioma notice headaches, seizures, vision changes, or problems with memory and concentration.
Headaches are common and may feel more frequent, more persistent, or simply different from your usual pattern. Some people notice them more in the morning or when coughing, bending, or straining.
A seizure can cause staring spells, unusual smells or sensations, jerking, or a brief loss of awareness. In some people, one of the early symptoms of middle cranial fossa meningioma is a first seizure after never having had one before.
Pressure near the nerves that control the eyes can lead to blurred vision, double vision, or trouble moving one eye normally. Some people also notice eyelid drooping or pain around the eye.
If nearby nerves or brain areas are affected, hearing may seem muffled and ringing in the ear can happen. Some people feel dizzy, unsteady, or off balance when walking.
How people usually first notice Middle cranial fossa meningioma?
Many people first notice a middle cranial fossa meningioma through slow, nagging symptoms that do not seem dramatic at first, such as headaches that keep returning, changes in vision, hearing, or balance, or a new feeling of facial numbness or weakness. Because this tumor grows in a part of the skull near nerves that help control the eyes, face, and hearing, some may also first notice double vision, ringing in the ears, trouble chewing, or episodes that look like seizures. In some people, the first signs of middle cranial fossa meningioma are found by chance on a brain scan done for another reason, which can be reassuring because these tumors often grow slowly and symptoms can vary depending on exactly where the tumor is pressing.
Types of Middle cranial fossa meningioma
No distinct types of Middle cranial fossa meningioma are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes can meaningfully delay the start of symptoms from a middle cranial fossa meningioma, which is usually a slow-growing tumor in the lining near the side of the base of the skull; when symptoms begin is mostly tied to where it sits and whether it grows. Healthy habits like regular activity, good sleep, and managing blood pressure may help overall well-being, but they have not been shown to reduce the risk of tumor-related symptoms starting, and they do not prevent the condition. If the tumor has already been found, the most established medical approach is regular follow-up scans and visits with a specialist so changes can be caught early, which can help guide treatment at the right time even though it cannot guarantee symptoms will be avoided.
What genetics can tell you about symptoms
For people with a middle cranial fossa meningioma, genetics can sometimes help explain why the tumor developed and how it may behave, but symptoms are usually driven more by where the tumor sits and how much it presses on nearby nerves or brain tissue than by a specific gene change. Some genetic changes in meningiomas are linked with faster growth, a higher chance of coming back, or certain tumor locations, which can indirectly affect how severe symptoms become, while rare inherited conditions such as neurofibromatosis type 2 can raise the chance of developing meningiomas at a younger age or having more than one tumor. In short, genetics may offer clues about timing and behavior, but they usually cannot predict the exact symptoms any one person will have.
Causes and risk factors
Doctors do not always know exactly why a middle cranial fossa meningioma forms. Risk goes up with age, and these tumors are more common in women, so hormones may play a role. One of the clearest risk factors for middle cranial fossa meningioma is past ionizing radiation to the head. Rare inherited conditions such as neurofibromatosis type 2 can raise risk, and obesity has also been linked. Think of risk factors as pieces of a puzzle, not the whole picture.
What are the most common causes or risk factors?
The exact cause of a middle cranial fossa meningioma, a growth in the lining around the brain near the base of the skull, is usually not known. The most clearly proven risk factors for meningiomas are older age, being female, and having had radiation to the head in the past. A small number are tied to inherited gene changes, especially a rare condition called neurofibromatosis type 2, which greatly increases the chance of developing these tumors.
Environmental and biological risk factors
Middle cranial fossa meningioma is a type of meningioma that starts in the lining around the brain in the middle part of the skull base. The main risk factors for middle cranial fossa meningioma are similar to those for meningiomas in other parts of the skull. Some risks are carried inside the body, others come from the world around us. In many people, no single clear cause is found.
Middle cranial fossa meningioma is much more common in adults than in children. The chance of developing it rises with age, especially from midlife onward.
Meningiomas are seen more often in women than in men. This difference suggests that natural hormone-related body factors may play a role, although the exact link is not fully understood.
Past exposure to ionizing radiation is the clearest environmental risk factor for meningioma. Risk is higher after radiation to the head or face, and it can remain elevated for many years.
Radiation exposure early in life appears to raise risk more than the same exposure in adulthood. That is why doctors pay close attention to any history of childhood radiation treatment.
Genetic risk factors
Most people with middle cranial fossa meningioma do not inherit it from a parent. When people ask whether middle cranial fossa meningioma is hereditary, the answer is usually no, but there are important exceptions. Some risk factors are inherited through our genes. In many cases, the main genetic driver is a DNA change that happens only in the tumor itself, while rare family syndromes can raise the chance of developing one or more meningiomas.
Tumor gene changes: Most middle cranial fossa meningiomas are linked to DNA changes that arise only in the tumor and are not passed down through families. Changes in genes such as TRAF7, AKT1, KLF4, SMO, POLR2A, and sometimes NF2 are seen, with the pattern varying by the exact skull-base site and tumor type.
NF2 changes: An inherited NF2 gene change is the strongest known family risk for meningiomas. People with this condition may develop meningiomas at a younger age and can have more than one tumor over time.
SMARCB1 changes: Rare inherited changes in SMARCB1 can lead to a family tendency to develop meningiomas. This may be suspected when several relatives have meningiomas or certain nerve-related tumors.
SMARCE1 changes: Inherited SMARCE1 changes are most strongly linked to clear cell meningioma, an uncommon subtype that often shows up earlier in life. If a middle cranial fossa meningioma has this subtype under the microscope, doctors may consider genetic counseling or testing.
BAP1 changes: Rare inherited BAP1 changes can increase the risk of meningioma and are sometimes linked to tumors that behave more aggressively. A strong family history of several different cancers may make doctors think about this possibility.
Family history: Having close relatives with meningioma can suggest a genetic susceptibility, even if no gene has been identified yet. This matters more when tumors appear across generations, at younger ages, or when one person develops multiple meningiomas.
Lifestyle risk factors
Lifestyle factors are not the main drivers of a middle cranial fossa meningioma, and research on them is less certain than for many other conditions. Still, some habits may influence overall meningioma risk, symptom burden, or how well a person tolerates treatment and recovery. When people ask about lifestyle risk factors for middle cranial fossa meningioma, the strongest practical links are usually body weight, activity level, alcohol, smoking, and general metabolic health. Diet and exercise matter mostly through their effects on weight, inflammation, cardiovascular fitness, and recovery.
Overweight and obesity have been linked in several studies to a higher chance of developing meningioma. Extra body fat can alter hormone and growth-factor signaling in ways that may support tumor growth. Keeping weight in a healthy range may lower risk and can also improve surgical and anesthesia safety if treatment is needed.
Physical inactivity can worsen weight gain, insulin resistance, and systemic inflammation, which may indirectly raise meningioma risk. Regular exercise also helps preserve balance, endurance, and conditioning before surgery or radiation. For people with symptoms such as fatigue or mild disequilibrium, tailored activity may improve daily function.
No single food is known to cause a middle cranial fossa meningioma, but a diet that promotes obesity and poor metabolic health may work against long-term brain tumor care. Eating patterns centered on vegetables, fruits, legumes, whole grains, and lean proteins can support weight control and recovery. Good nutrition is especially important if headaches, surgery, or treatment side effects reduce appetite.
Heavy alcohol use has not shown a clear, consistent link with meningioma formation, but it can still complicate care. It may worsen sleep, dehydration, headaches, medication interactions, and recovery after surgery. Limiting alcohol is a sensible part of how lifestyle affects middle cranial fossa meningioma management.
Risk prevention
There is no sure way to prevent middle cranial fossa meningioma, because many cases happen without a clear, controllable cause. For most people, prevention is really about lowering known risks where possible and finding the tumor early if symptoms appear. Prevention is about lowering risk, not eliminating it completely. If you notice ongoing headaches, new vision changes, seizures, or other early symptoms of middle cranial fossa meningioma, timely medical care can matter.
The clearest known avoidable risk for meningioma is exposure to ionizing radiation, especially to the head. Most people should not avoid needed scans or cancer treatment, but unnecessary radiation should be minimized whenever possible.
Some meningiomas may grow in response to hormones, so long-term hormone medicines should be reviewed with your doctor if benefits and risks are unclear. This is especially relevant if you have a past meningioma, a strong family history, or a tumor that changed during pregnancy or hormone treatment.
Obesity has been linked with a higher risk of meningioma in some studies. Reaching and keeping a healthy weight through food choices, regular activity, and sleep may help lower overall risk.
A small number of people develop meningiomas because of inherited conditions such as NF2-related disorders, and the tumor itself may not be fully preventable in that setting. Knowing your risks can guide which preventive steps matter most.
Can you prevent Middle cranial fossa meningioma?
No, a middle cranial fossa meningioma usually cannot be fully prevented, because these tumors often develop for reasons you cannot control. The clearest known way to lower risk is to avoid unnecessary radiation to the head when possible, although medical scans or treatment should still be done when they are truly needed. In many people, there is no proven way to stop it from happening.
Transmission
Middle cranial fossa meningioma is not an infection, so it cannot be caught from someone else through touch, breathing, sex, food, or blood. It is not contagious at all.
If you are worried about how Middle cranial fossa meningioma is inherited, the key point is that most cases are not passed from parent to child and develop by chance over time in the lining around the brain. A small number are linked to rare inherited conditions that raise the risk of meningiomas, but even then, what is passed down is a higher chance of developing the tumor, not the tumor itself.
When to test your genes
Gene testing is not routine for most people with a middle cranial fossa meningioma. It is worth discussing if the tumor appears at a young age, if there are multiple meningiomas, or if you or relatives have features suggestive of an inherited condition such as NF2. Tumor testing after surgery can sometimes help refine prognosis and follow-up.
Diagnosis
Middle cranial fossa meningioma is often found after ongoing symptoms such as headaches, seizures, changes in vision, hearing trouble, or numbness in the face lead to a medical workup. Because this tumor grows near important nerves and blood vessels at the base of the skull, diagnosis usually depends on symptoms, a careful exam, and brain imaging. It’s natural to worry when symptoms don’t have a clear explanation. In many cases, the diagnosis of Middle cranial fossa meningioma becomes clearer once imaging shows a mass in this area.
Doctors usually begin by asking about symptoms, when they started, and whether they have been getting worse over time. A detailed family and health history can help rule out other causes of headaches, seizures, vision changes, or facial symptoms.
A neurologic exam checks strength, sensation, balance, reflexes, speech, and memory. Doctors also look for signs that nerves passing through the middle skull base may be affected, such as double vision, facial numbness, or hearing changes.
MRI with contrast is the main test used to diagnose a Middle cranial fossa meningioma. It shows the size and exact location of the tumor and how it relates to nearby brain tissue, nerves, and blood vessels.
CT scans can help show changes in the skull base, including pressure on nearby bone or areas where the bone has thickened. This can add useful detail when doctors are planning treatment or trying to confirm what the MRI suggests.
How is Middle cranial fossa meningioma diagnosed?
Doctors usually suspect a middle cranial fossa meningioma after symptoms such as headaches, seizures, vision changes, or weakness lead to a brain scan, most often an MRI and sometimes a CT scan, which can show a growth near the side of the skull at the base of the brain. A full nerve and brain exam also helps show how the tumor is affecting the body, and the diagnosis is often confirmed by looking at tumor tissue after surgery or, less often, after a biopsy, which is a small tissue sample. Genetic testing is not usually needed to diagnose it, but it may be used in some people if doctors are concerned about an inherited condition or need more information for treatment planning.
Stages of Middle cranial fossa meningioma
Middle cranial fossa meningioma does not have defined progression stages. That is because it is usually described by where the tumor is, how fast it is growing, and whether it is causing symptoms, rather than by a set step-by-step course over time. Early symptoms of middle cranial fossa meningioma can be subtle, such as headaches, vision changes, seizures, or trouble with hearing or balance, while some people have no symptoms and the tumor is found on a scan done for another reason. Doctors usually start with a conversation about symptoms and a neurological exam, then use imaging tests such as MRI or CT scans to diagnose and monitor the tumor over time.
Outlook and prognosis
The outlook for a middle cranial fossa meningioma is often favorable when the tumor is benign, slow growing, and can be safely removed or controlled with radiation. Prognosis depends on tumor size, exact location near critical nerves and blood vessels, growth rate, histologic grade, and whether treatment achieves durable control without major neurologic injury. Many people have long-term survival, especially with World Health Organization grade 1 meningiomas, although symptoms such as seizures, vision changes, facial numbness, or cranial nerve deficits can persist or improve only partially depending on preoperative damage. Recurrence risk varies widely, being lowest after complete resection of a benign tumor and higher when only partial removal is possible or when the tumor is atypical or anaplastic. Mortality is generally low for benign lesions treated successfully, but the risk rises with larger tumors, older age, significant comorbidities, postoperative complications, or higher-grade meningioma. Lifelong imaging follow-up is often recommended because even otherwise indolent tumors can recur years later.
Long-term effects
Many people with middle cranial fossa meningioma do well for years, especially when the tumor is small, slow-growing, or treated successfully. The long-term picture is often shaped by where the tumor presses, whether it can be fully removed, and whether it comes back over time. Some people have few lasting problems, while others live with ongoing nerve-related changes such as headaches, vision changes, or seizures. It’s important to remember that long-term doesn’t always mean progressive, and outlook can vary widely from one person to another.
Some middle cranial fossa meningiomas stay stable for a long time, while others slowly enlarge and cause more pressure on nearby brain tissue and nerves. When considering what lies ahead, this can affect long-term follow-up needs and whether treatment is needed later.
Seizures can remain a long-term issue in some people, especially if the tumor has irritated nearby brain tissue. Even after treatment, anti-seizure medicine may still be needed for months or longer in some cases.
Ongoing headaches can happen if there is lasting pressure, irritation of nearby structures, or changes after surgery or radiation. For many, symptoms improve after treatment, but some continue to have recurring headaches that need monitoring.
Because this area is close to nerves involved in sight and eye movement, some people have lasting double vision, blurry vision, or trouble moving one eye normally. Early symptoms of middle cranial fossa meningioma can sometimes include these changes, and in some cases they do not fully reverse.
How is it to live with Middle cranial fossa meningioma?
Living with a middle cranial fossa meningioma can feel unpredictable because some people have few day-to-day problems, while others may deal with headaches, fatigue, seizures, vision changes, hearing changes, or trouble with memory and concentration depending on the tumor’s size and exact location. For many, daily life is shaped not only by symptoms but also by monitoring scans, medical appointments, treatment decisions, and temporary limits on driving, work, or independent activities if seizures or neurologic symptoms occur. This can affect the people around you too, as family and friends may help with transportation, appointments, medication schedules, and emotional support, especially during recovery from surgery or radiation, but many people still maintain meaningful routines and improve with treatment and follow-up care.
Treatment and drugs
Middle cranial fossa meningioma is usually treated based on the tumor’s size, growth, symptoms, and how close it is to important nerves and blood vessels at the base of the skull. If it is small and not causing problems, doctors may recommend regular MRI scans and checkups, while tumors that cause seizures, headaches, vision changes, or weakness are more likely to need treatment. Treatment plans often combine several approaches. Surgery is often the main treatment when the tumor can be removed safely, and radiation therapy may be used instead of surgery or after surgery to slow or stop remaining tumor cells from growing. Medicines do not usually shrink a middle cranial fossa meningioma itself, but they can help manage symptoms such as seizures, swelling, or pain, and your care team may also talk with you about rehabilitation if the tumor or treatment affects speech, movement, or daily tasks.
Can you cure Middle cranial fossa meningioma?
Sometimes, yes: if a middle cranial fossa meningioma can be fully removed, treatment may be curative. But for many living with this kind of tumor near the base of the skull, a full cure is not always possible because it may be too close to important nerves or blood vessels, so treatment often uses surgery, radiation, and regular scans to control growth, ease symptoms, and watch for it to come back.
Non-drug treatment
Living with a middle cranial fossa meningioma can affect day-to-day life in very practical ways, from headaches and facial numbness to changes in hearing, vision, or balance, depending on where the tumor is pressing. Non-drug care may include close monitoring, procedures to remove or shrink the tumor, and therapies that help with recovery and daily function. Not every approach works the same way, and the best plan depends on the tumor’s size, growth rate, location, symptoms, and your overall health. For some people, treatment for middle cranial fossa meningioma without surgery may be an option when the tumor is small, slow-growing, or causing few problems.
Small tumors that are not causing major symptoms may be watched with regular MRI scans and follow-up visits. This helps track growth and can spare people with middle cranial fossa meningioma from treatment they do not need right away.
Surgery is often used when the tumor is growing, pressing on nearby nerves or brain tissue, or clearly causing symptoms. The goal is to remove as much of the meningioma as is safely possible while protecting functions such as vision, hearing, facial movement, and speech.
Focused radiation can be used after surgery if some tumor remains, or instead of surgery in selected cases. Techniques such as stereotactic radiosurgery or fractionated radiation aim to slow or stop growth while limiting damage to nearby tissue.
Physical, occupational, and speech therapy can help if the tumor or its treatment affects balance, strength, swallowing, communication, or everyday tasks. For many, treatment begins not at the pharmacy, but with structured rehab that supports a safer return to work, driving, or home routines.
Your genes may have an impact on how drugs work for you
For people with a middle cranial fossa meningioma, medicine is often used more to help with symptoms, such as seizures, swelling around the tumor, or pain, than to treat the growth itself. Small inherited differences in the body can change how quickly these medicines are broken down or how strongly they work, so one person may get good relief at a usual dose while another may feel very sleepy, have more side effects, or need a different amount. This is not something that changes care for everyone, but if treatment is not working as expected or side effects are unusually strong, doctors may consider whether inherited differences could be part of the reason.
Pharmacological treatments
For middle cranial fossa meningioma, medicines are usually used to control symptoms or swelling rather than remove the tumor itself. The main treatment is often surgery, radiation, or both, but drugs can still make day-to-day life easier by easing headaches, seizures, nausea, or pressure-related symptoms. In people with recurrent or hard-to-treat middle cranial fossa meningioma, a few drug treatments may be considered, although their benefit is often modest. Not everyone responds to the same medication in the same way.
Dexamethasone is a corticosteroid often used to reduce brain swelling around the tumor. This can ease headaches, nausea, vision changes, or worsening weakness while other treatment is being planned or after surgery or radiation.
If the tumor causes seizures, drugs such as levetiracetam, lacosamide, or valproic acid may help prevent more episodes. These medicines do not treat the meningioma itself, but they can make daily life safer and more predictable.
Acetaminophen and sometimes other headache medicines may be used when middle cranial fossa meningioma causes ongoing head pain or pressure. Doctors choose carefully because some pain relievers are less suitable around the time of surgery or if there is a bleeding risk.
Medicines such as ondansetron or prochlorperazine may be used if raised pressure, treatment, or severe headaches lead to nausea or vomiting. They are supportive treatments meant to improve comfort and help with eating, drinking, and recovery.
Genetic influences
Most middle cranial fossa meningiomas are not inherited from a parent. Instead, they usually develop because of gene changes that happen in the tumor cells over time, not changes you were born with. A change in a gene can sometimes affect health, and in meningiomas these changes often involve genes such as NF2 and, in some skull base tumors, AKT1, SMO, TRAF7, or KLF4. For many living with middle cranial fossa meningioma, this means the tumor is considered sporadic rather than something that clearly runs in the family. Inherited risk is uncommon, but it can be higher in people with certain genetic conditions, especially neurofibromatosis type 2, or when someone develops meningiomas at a younger age or has more than one tumor. If there is a strong family history or unusual features, doctors may suggest genetic counseling or testing to help clarify whether genetics played a larger role.
Is Middle cranial fossa meningioma genetic?
Genetics usually matter less for middle cranial fossa meningioma than for many inherited conditions, since most cases are not clearly passed down in families. Still, gene changes in the tumor can affect growth, and rare inherited syndromes can raise risk.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human and are common throughout the general population. Most of these variants do not directly affect health and are simply part of normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with a middle cranial fossa meningioma, the main treatment is usually surgery and sometimes radiation, so genetics does not often shape care the way it can for diseases treated mainly with medication. Changes in the tumor’s own genes can still matter, because they may give doctors clues about how the tumor is likely to behave and whether a targeted drug or clinical trial might be worth discussing if it comes back or cannot be fully removed. Not every difference in response is genetic, but inherited gene differences can affect how some people process medicines often used around treatment, such as anti-seizure drugs, pain relievers, steroids, or blood thinners. That can help explain why one person feels very sleepy on an anti-seizure medicine while another does well on the same dose. For most people, genetic testing is used more to learn about the tumor than to choose among the drugs used to treat middle cranial fossa meningioma, because there are still few standard medicines that directly treat this tumor. Your care team will usually combine any genetic information with the tumor’s location, symptoms, scan results, and your overall health when deciding on treatment.
Interactions with other conditions
Symptoms from a middle cranial fossa meningioma can be easy to confuse with other neurologic problems, especially migraine, stroke, seizure disorders, or inner ear conditions that cause dizziness or hearing changes. Someone might notice their symptoms flare when another condition is active, which can make it harder to tell whether new headaches, facial numbness, double vision, or balance problems are coming from the tumor or something else. Because this tumor sits near important nerves and blood vessels at the base of the brain, it can overlap with eye movement disorders, trigeminal nerve pain, and some causes of hearing loss, so doctors often need brain imaging to sort out the cause. People with a genetic condition called neurofibromatosis type 2 may be more likely to develop meningiomas, including ones in this area, and they may also have other nerve tumors at the same time. If someone already lives with epilepsy or has had a prior stroke, a middle cranial fossa meningioma can complicate symptom tracking and treatment decisions. For many, this means care works best when neurology, neurosurgery, and sometimes eye or ear specialists look at the full picture together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Middle cranial fossa meningioma?
Other problems in the same part of the head can cause similar symptoms, especially other growths near the base of the brain, such as nerve tumors near the ear or face, pituitary tumors behind the eyes, or cancer that has spread to the brain. Depending on what symptoms come first, a stroke, severe migraine, or some inner ear problems can also be mistaken for it at first. Doctors usually sort these apart with brain scans and a careful nerve exam.
History
People living with middle cranial fossa meningioma are often dealing with very current concerns, like headaches that keep returning, changes in vision, or trouble hearing on one side, but the story of this tumor reaches back much further than modern brain scans. Meningiomas were recognized long before doctors could see them clearly in living patients, based mostly on symptoms and what surgeons or pathologists found after death or during early operations.
In recent decades, awareness has grown, but the medical understanding of middle cranial fossa meningioma developed step by step. Early doctors described tumors arising from the coverings of the brain rather than the brain tissue itself, which was an important shift because it helped explain why some growths pressed on nearby nerves and structures instead of spreading through the brain. As medical science evolved, better anatomy studies made it possible to link certain symptoms with tumors in the middle cranial fossa, an area near the temples that sits close to nerves involved in vision, facial feeling, eye movement, and hearing. For many, this can mean symptoms that seem unrelated at first, such as double vision, facial numbness, or gradual hearing changes.
The history of treatment also changed dramatically over time. In the late 1800s and early 1900s, brain surgery became more organized and safer, and surgeons slowly learned which meningiomas might be removed and which posed greater risk because of their location near major blood vessels and delicate nerves. A middle cranial fossa meningioma could be especially challenging because even a slow-growing tumor in this area may affect tightly packed structures. In everyday life, this might look like someone first blaming new balance trouble or a drooping eyelid on stress, only to learn there is pressure from a tumor nearby.
Later, CT and then MRI transformed care by allowing doctors to see these tumors before surgery and follow them over time. That changed the experience for many living with middle cranial fossa meningioma, because doctors could more accurately judge size, growth, and the safest treatment plan, including monitoring, surgery, or radiation. Researchers also came to understand that meningiomas are not all the same: many are slow growing and noncancerous, while a smaller number behave more aggressively. Knowing this history helps explain why today’s care is usually built around the tumor’s exact location, symptoms, growth pattern, and the person’s overall health, rather than a one-size-fits-all approach.